In melanoma development, proliferation, invasion, and survival, there is evidence for the increased expression of erythroid nuclear-related factor 2 (NRF2) [83], a fundamental player in the antioxidant response that ensures tumour survival to ROS damage [37]. Here, NFE2L2 is linked to neoplasm.